A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands

Gout

Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis

BMJ Open.

Yin R, Li L, Zhang G, Cui Y, Zhang L, Zhang Q, Fu T, Cao H, Li L, Gu Z

doi: 10.1136/

Gout

Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study

Rheumatology (Oxford).

Ebstein E, Forien M, Norkuviene E, Richette P, Mouterde G, Daien C, Ea HK, Brière C, Lioté F, Petraitis M, Bardin T, Ora J, Dieudé P, Ottaviani S

doi: 10.1093/rheumatology/key303.

Gout

Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase

J Rheumatol.

Pillinger MH, Fields T, Yeo AE, Lipsky PE

doi: 10.3899/jrheum.190161.

Gout

Effects of conventional uric acid lowering therapy on monosodium urate crystal deposits

Arthritis Rheumatol.

Ellmann H, Bayat S, Araujo E, Manger B, Kleyer A, Cavallaro A, Lell M, Schenker H, Simon D, Tascilar K, Baraf HSB, Schett G, Rech J

doi: 10.1002/art.41063.

Gout

Comorbidity clusters in people with gout: an observational cohort study with linked medical record review

Rheumatology (Oxford).

Bevis M, Blagojevic-Bucknall M, Mallen C, Hider S, Roddy E

doi: 10.1093/rheumatology/

Gout

Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis

Semin Arthritis Rheum

Son CN, Stewart S, Su I, Mihov B, Gamble G, Dalbeth N

doi: 10.1016/j.semarthrit.2021.04.011

COMMENTED

Gout

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout

Rheumatology (Oxford).

Terkeltaub R, Saag KG, Goldfarb DS, Baumgartner S, Schechter BM, Valiyil R, Jalal D, Pillinger M, White WB

doi: 10.1093/rheumatology/key245.

Gout

Associations of gout and baseline serum urate with cardiovascular outcomes: analysis of the Coronary Disease Cohort Study

Arthritis Rheumatol.

Stamp LK, Frampton C, Drake J, Doughty RN, Troughton RW, Richards AM

doi: 10.1002/art.41007.

Gout

Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis

Clin Rheumatol.

Gamala M, Linn-Rasker SP, Nix M, Heggelman BGF, van Laar JM, Pasker-de Jong PCM, Jacobs JWG, Klaasen R

doi: 10.1007/s10067-018-3980-y.

Related content

Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis

Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study

Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase

Effects of conventional uric acid lowering therapy on monosodium urate crystal deposits

Comorbidity clusters in people with gout: an observational cohort study with linked medical record review

Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout

Associations of gout and baseline serum urate with cardiovascular outcomes: analysis of the Coronary Disease Cohort Study

Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis